لماذا يتناول سام ألتمان الميتفورمين؟
استخبارات GeoGazet· تم التحديث 5 أكتوبر 2026· دقيقة واحدة قراءة· ٧٨٦ مشاهدة
There is no credible evidence that Sam Altman, OpenAI's CEO since 2019, takes metformin.
This claim lacks substantiation in public records, health disclosures, or verified reporting.
Altman's health information remains private.
اقرأ التقرير الكاملإظهار أقل
لماذا يتناول سام ألتمان الميتفورمين؟
Public Focus on AI Development
Altman's documented activities center on OpenAI's product roadmap. Recent initiatives include OpenAI Dots, his unveiled ChatGPT AI personal agent, alongside the 2026 DevDay announcements. His tracked signals show 94 connections to Artificial Intelligence developments.
Speculation Without Basis
Health rumors about prominent figures often circulate online without verification. Without direct statements from Altman or credible medical sources, claims about his medications should be treated as unsubstantiated speculation rather than fact.
تابع ألتمان مباشرة.يُنشر كل تحديث على قناتنا على تلغرام.
انضم على تلغراممراجعات القراء
لا توجد مراجعات بعد. كن أول من يشارك رأيه.